CAS 142356-43-2
:BDCRB (GW 275175)
Description:
BDCRB (GW 275175) is a chemical compound that belongs to the class of small molecules known for their potential therapeutic applications, particularly in the field of cancer research. It is characterized by its specific molecular structure, which includes various functional groups that contribute to its biological activity. BDCRB acts as a selective inhibitor, targeting specific pathways involved in cell proliferation and survival, making it a subject of interest in studies related to tumor growth and metastasis. The compound's efficacy and safety profile are typically evaluated through preclinical and clinical trials, where its pharmacokinetics, bioavailability, and potential side effects are assessed. Additionally, BDCRB's solubility, stability, and reactivity are important characteristics that influence its formulation and delivery in therapeutic contexts. As research continues, the understanding of BDCRB's mechanism of action and its interactions with biological systems will further elucidate its role in medicinal chemistry and potential clinical applications.
Formula:C12H11BrCl2N2O4
Synonyms:- BDCRB
- 2-bromo-5,6-dichloro-1-β-D-ribofuranosylbenzimidazole
- (GW 275175)
- 1H-Benzimidazole, 2-bromo-5,6-dichloro-1-β-D-ribofuranosyl-
- 1H-Benzimidazole, 2-bromo-5,6-dichloro-1-β-D-ribofuranosyl-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 1 products.
